Attention deficit hyperactivity disorder, combined type: better executive function performance with longer-term psychostimulant medication

Aust N Z J Psychiatry. 2003 Oct;37(5):570-6. doi: 10.1046/j.1440-1614.2003.01238.x.

Abstract

Objective: Executive function deficits are evident in primary school-age children with attention deficit hyperactivity disorder, combined type (ADHD-CT) and are possibly improved by longer-term psychostimulant medication. In contrast, a substantial subgroup of children with ADHD-CT become symptomatic despite longer-term psychostimulant medication use. We investigated the hypothesis that better executive function performance is associated with the use of longer-term psychostimulant medication in primary school-age children with ADHD-CT who are again symptomatic of ADHD-CT, despite its use.

Method: A cross-sectional study of 40 primary school-age psychostimulant medication-naïve children with ADHD-CT, 26 with symptomatic ADHD-CT and treated with psychostimulant medication, and 26 control children without ADHD-CT was conducted. Nonverbal tasks of executive function were compared across the three groups.

Results: The longer-term psychostimulant medication-treated group had a better executive function performance, despite being symptomatic for ADHD-CT, than the psychostimulant medication-naïve group.

Conclusion: Improved executive function may be a marker of psychostimulant medication effect in children with ADHD-CT treated in the longer term. This improvement may not correlate with that of the ADHD-CT symptoms. Longitudinal studies are required.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Attention Deficit Disorder with Hyperactivity / complications
  • Attention Deficit Disorder with Hyperactivity / diagnosis*
  • Attention Deficit Disorder with Hyperactivity / drug therapy*
  • Central Nervous System Stimulants / therapeutic use*
  • Child
  • Cognition Disorders / complications
  • Cognition Disorders / diagnosis*
  • Cross-Sectional Studies
  • Dextroamphetamine / therapeutic use*
  • Diagnosis, Computer-Assisted
  • Diagnostic and Statistical Manual of Mental Disorders
  • Female
  • Humans
  • Male
  • Methylphenidate / therapeutic use*
  • Severity of Illness Index
  • Time Factors
  • Wechsler Scales

Substances

  • Central Nervous System Stimulants
  • Methylphenidate
  • Dextroamphetamine